EUVIMEDOpdag EUVIMED
Crossref

Microperfused Biomimetic Liver‐on‐a‐Chip for High‐Throughput Hepatotoxicity Screening

Junqi Zhao, Danqing Huang, Jinglin Wang, Yuanjin Zhao iD

Small · 2025

DOI: 10.1002/smll.202505653 ↗

At a glance

Journal article in Small, 2025. Written by Junqi Zhao and 3 co-authors. Institution: Joint Centre of Translational Medicine, Wenzhou Institute of University of Chinese Academy of Sciences, The First Affiliated Hospital of Wenzhou Medi…. Major MEDLINE topics: Liver, Lab-On-A-Chip Devices, Biomimetics, High-Throughput Screening Assays. Cited 5 times so far (Crossref); 36 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Clinical Trials from Nanjing Drum Tower Hospital.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Liver‐on‐a‐chip has emerged as an effective tool for liver disease modeling and new drug development, while the current challenge lies in further mimicking liver physiological conditions. Here, inspired by the intricate architecture of hepatic lobules, a novel biomimetic vascularized liver‐on‐a‐chip fabricated via high‐precision 3D printing technology is presented. The chip features a capillary network with multiple micro‐pores, ensuring a constant nutrient supply and efficient substance exchange within the cell environment through microfluidic perfusion. Under microperfusion conditions, human induced pluripotent stem cell‐derived hepatocytes (hiPSC‐Heps) exhibit superior physiological status and biological functionality compared to traditional 2D cultures. In addition, a comprehensive platform for assessing drug‐induced liver injury (DILI) is established by integrating a concentration gradient chip, liver chips, and multicellular coculture technologies. This innovative platform effectively validates both acute and chronic hepatotoxic effects of acetaminophen (APAP). These findings demonstrate that the biomimetic vascularized liver‐on‐a‐chip exhibits ideal physiological relevance and holds significant potential for applications in drug development and toxicity screening.

Subjects

MeSH terms (MEDLINE)

LiverLab-On-A-Chip DevicesBiomimeticsHigh-Throughput Screening AssaysHumansHepatocytesInduced Pluripotent Stem CellsAcetaminophenChemical and Drug Induced Liver InjuryCoculture Techniques

Author keywords

3D printingbiomimeticdrug‐induced liver injuryliver‐on‐a‐chipmicroperfusionvascularized

Substances

Acetaminophen

Authors and institutions

  • Joint Centre of Translational Medicine, Wenzhou Institute of University of Chinese Academy of Sciences, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, P. R. China.
  • Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, P. R. China.
  • Institute of Organoids on Chips Translational Research, Henan Academy of Sciences, Zhengzhou, 450009, P. R. China.

ORCID profiles: Yuanjin Zhao

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Clinical Trials from Nanjing Drum Tower Hospital
  • Key Research & Development Program of Jiangsu Province
  • Henan Province Science and Technology R&D Program
  • Yangtze River Pharmaceutical Group

Cite

APA

Zhao, J., Huang, D., Wang, J., & Zhao, Y. (2025). Microperfused Biomimetic Liver‐on‐a‐Chip for High‐Throughput Hepatotoxicity Screening. Small. https://doi.org/10.1002/smll.202505653

Vancouver

Zhao J, Huang D, Wang J, Zhao Y. Microperfused Biomimetic Liver‐on‐a‐Chip for High‐Throughput Hepatotoxicity Screening. Small. 2025. doi:10.1002/smll.202505653

BibTeX
@article{Zhao2025,
  author = {Zhao, Junqi and Huang, Danqing and Wang, Jinglin and Zhao, Yuanjin},
  title = {Microperfused Biomimetic Liver‐on‐a‐Chip for High‐Throughput Hepatotoxicity Screening},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202505653}
}
Start for free →